Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

VZHE-039 demonstrates to be a promising novel potent antisickling agent

Jan. 5, 2017

Galena Biopharma gives update on regulatory plans for GALE-401

Dec. 29, 2016

Ropeginterferon alfa-2b shows promise in patients with polycythemia vera

Dec. 29, 2016

FDA expands indications for Shire's Adynovate

Dec. 28, 2016

BAX-930 shows potential in patients with hereditary thrombotic thrombocytopenic purpura

Dec. 28, 2016

FDA accepts betrixaban NDA for priority review, EMA validates MAA

Dec. 27, 2016

Helix BioPharma, ProMab Biotechnologies to establish CAR-T therapy collaboration

Dec. 23, 2016

Phase III study of emicizumab prophylaxis in hemophilia A meets primary endpoint

Dec. 22, 2016

Akebia and Otsuka Pharmaceutical collaborate to develop and commercialize vadadustat in the U.S.

Dec. 21, 2016

Apellis Pharmaceuticals' APL-2 earns fast track designation from FDA

Dec. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...